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Abstract
Introduction and Objective—To characterize enamel defects in patients with methylmalonic
acidemia (MMA) and cobalamin metabolic disorders and to examine salivary methylmalonate
levels in MMA.
Subjects and Methods—Teeth from patients (n=32) were evaluated for enamel defects and
compared with age- and gender-matched controls (n=55). Complementation class (mut, cblA,
cblB, cblC) and serum methylmalonate levels were examined. Primary teeth from two patients
were examined by light and scanning electron microscopy and salivary methylmalonate levels
from two patients were analyzed.
Results—Enamel defects were significantly more prevalent per tooth in the affected group than
the control group, across complementation types (p<0.0001). The mut MMA subgroup had a
significantly higher prevalence per individual of severe enamel defects than controls (p=0.021),
and those with enamel defects exhibited higher serum methylmalonate levels than those without
(p=0.017). Salivary methylmalonate levels were extremely elevated and were significantly higher
than controls (p=0.002). Primary teeth were free of enamel defects except for two cblC patients
who exhibited severe enamel hypoplasia. One primary tooth from a cblC patient manifested
markedly altered crystal microstructure.
Conclusion—Enamel anomalies represent a phenotypic manifestation of MMA and cobalamin
metabolic disorders. These findings suggest an association between enamel developmental
pathology and disordered metabolism.
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Introduction
The hereditary methylmalonic acidemias comprise a group of autosomal recessive
enzymopathies characterized by massive accumulation of methylmalonate and propionate-
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derived metabolites in the bodily fluids (Fenton et al., 2001). The collective incidence of
isolated methylmalonic acidemia in the population is unknown but likely lies between 1 in
50,000 to 100,000 births (Chase et al., 2001). Deficient activity of the methylmalonyl-
coenzyme A mutase (MUT) enzyme accounts for approximately half of all cases (Horster et
al., 2007) and over one hundred disease causing mutations have been identified at the MUT
locus (Acquaviva et al., 2005; Worgan et al., 2006). Impaired intracellular metabolism of
cobalamin (cbl) define another group of hereditary defects designated by the cellular
complementation status (cblA–F) (Fenton and Rosenblatt, 2001). These disorders can
feature isolated methylmalonic acidemia (cblA, cblB, cblD variant 2) caused by a functional
impairment of the methylmalonyl-CoA mutase reaction, combined methylmalonic acidemia/
aciduria-hyperhomocysteinemia/homocystinuria (cblC, cblD, cblF) or isolated
hyperhomocystinemia (cblD variant 1, cblE, cblG) (Adams and Venditti, 2008; Venditti,
2005). Figure 1 depicts the general steps of cobalamin metabolism and the location of the
main enzyme defects in this pathway (Chandler and Venditti, 2005).
The elevated metabolites universally present in individuals with isolated or combined
methylmalonic acidemia derive from endogenous catabolism of certain essential amino
acids (isoleucine, methionine, threonine, valine), odd chain fatty acids, and cholesterol, as
well as gut bacterial derived propionate (Leonard, 1997). These compounds are metabolized
to methylmalonyl-CoA, and then into succinyl-CoA, a Krebs cycle intermediate, via the
methylmalonyl-CoA mutase reaction. When this reaction is impaired, methylmalonic acid as
well as propionyl-CoA derived metabolites, such as 2-methylcitrate and 3-
hydroxypropionate, begin to accumulate in the body with detrimental effects (Ando et al.,
1972a; Ando et al., 1972b; Cheema-Dhadli et al., 1975).
Collectively, patients affected with these conditions display clinical and biochemical
heterogeneity. Those with MUT deficiency can exhibit failure-to-thrive, strokes, kidney
disease, pancreatitis, and early mortality (Baumgater and Viardot, 1995; deBaulny et al.,
2005; Horster et al., 2007; Matsui et al., 1983; Nicolaides et al., 1998; vanderMeer et al.,
1994). Extreme elevations of blood and urinary methylmalonic acid are typical and can rise
to the millimolar range (compared with normal nanomolar range) in the setting of crisis or
renal insufficiency (Walter et al., 1989). The mainstay of treatment includes protein
restriction to reduce the metabolite load as well as cofactor and carnitine supplementation
(deBaulny et al., 2005). Despite conventional medical management, mortality has remained
substantial and some severely affected patients have been treated using liver and/or
combined liver-kidney transplantation (Leonard et al., 2004). Disordered intracellular
metabolism of cobalamin produces another group of disorders named after the
corresponding cellular complementation class – cobalamin C (cblC), D and F. These
conditions are also heterogenous (Fenton and Rosenblatt, 2001; Rosenblatt et al., 1997),
clinically and biochemically, and present a spectrum of clinical phenotypes, ranging from
intrauterine growth retardation (Andersson et al., 1999) to adult onset neurodegeneration
(Powers et al., 2001). The dental phenotypes in all these disorders have remained
uninvestigated, even though bone demineralization, osteopenia, or osteoporosis, is often
observed (Baumgater and Viardot, 1995). The abnormalities of hard tissue mineralization
led us to begin observing the dental manifestations of these diseases.
Enamel is the most mineralized tissue in the body, with approximately 97% by weight
mineral content, and is made up of small calcium phosphate crystallites oriented in a specific
pattern to form enamel prisms (Robinson et al., 2003). Enamel formation is a complex and
highly regulated process involving the secretion and processing of a protein extracellular
matrix and the regulation of ion flow and crystal growth (Fincham et al., 1999; Simmer and
Fincham, 1995). Initial calcification of a primary human anterior tooth begins at 14–17
weeks in utero and enamel formation is completed at 1–9 months after birth. Permanent
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human anterior teeth begin calcification at 3–12 months and complete enamel formation at
4–7 years of age (Ash and Nelson, 2003). Once developed, enamel remains fairly inert,
biologically non-responsive to internal stimuli, and functions without further remodeling
(Hu et al., 2007). The presence of enamel defects, therefore, may be highly dependent on
conditions occurring during the critical time of enamel formation and mineralization.
Enamel defects have been associated with pediatric systemic illnesses during the critical
period of enamel formation (Bhat and Nelson, 1989; Kusiak et al., 2007; Lucas and Roberts,
2005; Pindborg, 1982; Russell et al., 1996). Enamel anomalies have also been described in
patients with specific metabolic disorders, such as phenylketonuria, an amino acid disorder
(Lucas et al., 2001; Myers et al., 1968), and in those with mucopolysaccharidoses, a group
of lysosomal storage diseases (Barker and Welbury, 2000; Guven et al., 2008; Rølling et al.,
1999). However, the consequences of the effects of inborn errors of organic acid metabolism
on enamel development have not been examined.
The objective of the current study was to characterize enamel defects in a group of patients
with methylmalonic acidemia and cobalamin metabolic disorders. These findings were then
investigated for association with complementation status and serum methylmalonate
concentrations. Microstructural analysis of two deciduous teeth and salivary methylmalonate
level analysis from two mut deficient patients was also performed.
Materials and Methods
Thirty-two individuals with methylmalonic acidemia or cobalamin metabolic disorders,
designated the affected group, were evaluated as part of the National Institutes of Health
study 04-HG-0127 “Clinical and Basic Investigations of Methylmalonic Acidemia and
Related Disorders” after informed consent was obtained. Patient studies were conducted in
compliance with the Helsinki Declaration and were approved by the Institutional Review
Boards of the National Human Genome Research Institute and the National Institute of
Dental and Craniofacial Research. Fifty-five age- and gender-matched individuals enrolled
in other NIH protocols, but not diagnosed with an inborn error of metabolism and transport,
received dental evaluation and comprised the control group. Exclusion criteria for the
control group included hereditary diseases that have enamel or dentin defects associated
with its phenotype, such as osteogenesis imperfecta, amelogenesis imperfecta, Turner
syndrome, cystic fibrosis, hypoparathyroidism, and rickets.
All patients with methylmalonic acidemia and cobalamin metabolic defects had diagnoses
confirmed by cellular biochemical studies and/or mutation analysis (Chandler et al., 2007;
Lerner-Ellis et al., 2005; Worgan et al., 2006). Affected individuals were divided into two
groups based on whether they possessed permanent (n=22 subjects) or primary (n=10
subjects) maxillary anterior incisors. Table 1 shows the affected groups and the control
group characteristics. Serum or salivary methymalonic acid was determined for the affected
group by either electrospray tandem mass spectrometry (Magera et al., 2000) or by gas
chromatography-mass spectrometry with stable isotopic internal calibration (Allen et al.,
1993). The serum methylmalonate levels were determined near the time of dental
evaluation. Ten study subjects had received combined liver-kidney or kidney transplants.
All subjects (affected and control groups) received a comprehensive dental evaluation,
including an examination for developmental anomalies of tooth number and dental structural
defects. Radiographic evaluation included a panograph and intraoral radiographs. Intraoral
photographs of the anterior teeth were taken on all subjects. Facial aspects of index
maxillary anterior index teeth (#7, 8, 9, 10) were reviewed by the same dentist and assigned
enamel defect scores using the Modified Developmental Defects of Enamel (DDE) Index
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(Clarkson, 1989). In this Index, both a coding score (0–9) indicating type of enamel defect
(with a higher number indicating a more severe type of defect) and an extent (0–3) of
enamel defect (indicating the area of tooth surface affected) is determined. A score of 0
indicates normal enamel, a score of 1–2 indicates demarcated opacities, a score of 3–6
indicates diffuse opacities or lining, and a score of 7–9 indicates hypoplasia in the form of
pitting or missing enamel. A second dentist, blinded to the study subject's diagnosis,
reviewed the photographs and also assigned DDE scores to the index teeth. The average of
the two scorers was used for analysis.
The prevalence of the types of enamel defect between groups was then compared to
determine differences of DDE types for index teeth. The prevalence of an individual having
at least one index tooth with severe enamel defects was then compared across groups, with a
severe enamel defect defined as a DDE score of ≥ 3. The difference in extents between
groups was also compared.
Microstructural analysis was performed on exfoliated deciduous teeth from two affected
patients, a 10 year-old Caucasian female with mut MMA (tooth L) and a 9 year-old
Caucasian female diagnosed with cblC (tooth N). Each tooth was sectioned and analyzed
with light microscopy (LM) and with scanning electron microscopy (SEM). Thin sections
approximately 100 microns thick were cut with a diamond disc for LM examination. Using
SEM, fractured enamel samples were examined after removal of organic material using
NaOCl as described previously (Wright et al., 1993).
Further, two of the patients with mut methylmalonic acidemia provided unstimulated, whole
saliva samples that were collected concurrently with blood samples for determination of
methylmalonic acid concentrations. The levels were compared to two healthy control saliva
and blood samples collected in an identical fashion.
Statistical analyses were performed using the R statistical analysis package (R Development
Core Team, 2006). Normally distributed continuous variables were expressed as means ±
SD. Student's t tests were used to analyze continuous differences in groups. A Chi-Square
test with Fisher's exact test for significance was used to examine frequency differences
between groups. A multivariant regression analysis was used to determine the associations
between groups while accounting for the influence of confounders. Two-tailed p values <
0.05 were considered statistically significant.
Results
No significant difference was found between the first and second scorers for DDE score or
DDE extents for each index tooth, indicating intra-scorer reliability (p > 0.75). For affected
subjects with permanent maxillary central incisors, no significant differences in age (p =
0.664) or gender (p = 0.803) were found between the affected (n = 22) and control (n = 45)
groups (Table 1). The prevalence of severe enamel defects in the teeth of affected subjects
was significantly higher when compared with controls, for both diffuse opacities (p <
0.0001) and for hypoplasia (p < 0.0001). The prevalence of the number of subjects who had
at least one tooth with a severe enamel defect, of at least a diffuse opacity, was significantly
higher in the affected group than controls (p = 0.010). The extents of the defects were also
significantly greater in the affected group when compared with the control group (p <
0.0001, Table 2).
An analysis of the enamel defects in teeth between various complementation types for
affected patients with permanent index teeth (n=22) showed no significant association
between the specific metabolic defect and type of enamel defect. All the metabolic subtypes
examined demonstrated severe enamel defects (diffuse opacities or hypoplasia) on teeth with
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a significantly higher prevalence when compared to controls (p < 0.0001). However, the
prevalence of the number of subjects who had at least one tooth with a severe enamel defect,
of at least a diffuse opacity, was significantly higher only in the mut MMA subgroup when
compared with the control group (p = 0.021).
Figure 2 shows a clinical photo of the teeth of a control subject with normal enamel and
several affected subjects with a spectrum of severe enamel defects, demonstrating diffuse
opacities and enamel pitting.
For subjects with permanent index teeth (n=22), those who demonstrated severe enamel
defects (diffuse opacities or enamel hypoplasia, n = 12) had significantly higher serum
methylmalonic acid levels than those without (n=10) (1467.33 ± 1662.78 vs. 150.42 ±
209.28 μmol/L, p=0.022). Within the mut MMA subgroup (n=15), where serum
methylmalonate levels can be expected to be elevated, the subjects who had severe enamel
defects (n = 8, 5 transplant subjects (62%), 2050.50 ± 620.48 μmol/L) had significantly
higher serum levels of methylmalonic acid than those without (n = 7, 2 transplant subjects
(29%), 209.57 ± 86.24 μmol/L, p = 0.017) (Figure 3). This association of DDE scores with
serum levels of methymalonic acid remains significant, even when adjusted for transplant
status (p = 0.040). No trend towards congenitally missing or supernumerary teeth was found
in the affected group.
For subjects with primary maxillary central incisors, no significant differences in age (p =
0.075) or gender (p = 0.656) were found between the affected (n = 10) and control (n = 10)
groups (Table 1). The prevalence of severe enamel defects in the teeth of affected subjects
were significantly higher when compared with controls (p = 0.044), wholly due to two cblC
subjects who exhibited very severe enamel defects of generalized missing enamel (Table 2).
For this cblC subgroup, the prevalence of the number of subjects who had at least one tooth
with a severe enamel defect, here severe enamel hypoplasia, was significantly higher than
the control group (p = 0.038). Figure 4 shows a control subject with primary teeth covered
with normal enamel and the two cblC affected subjects with cone-shaped, severely
dysmorphic primary teeth and radiographic evidence of enamel hypoplasia.
Both primary teeth provided by the affected subjects for microstructural analysis were
grossly normal morphologically (Figure 5A and B). Microstructurally, the tooth sample
from the mut patient (molar) was found to have normal enamel thickness and regular
crystalline structure. In contrast, the tooth sample from the cblC patient (incisor) was found
to have normal enamel thickness but markedly altered microstructure. As seen by light
microscopy of thin sections, the incisor sample had altered enamel opacity indicative of
increased porosity as compared with the molar sample (Figure 5C and D). Also, when
viewed with SEM, the incisor enamel showed flat, plate-like crystallites that were
intermixed with the more classically normal appearing hexagonal enamel crystal that were
seen throughout in the normal appearing molar sample (Figure 5E and F).
Salivary levels of methylmalonic acid were massively elevated in the two mut patients
whose saliva was tested (21,904 ± 1438 nmol/L) when compared to two control salivary
concentrations (427 ± 142 nmol/L, p=0.002). This finding parallels the difference in the
serum levels of MMA in the patients (191,887 ± 103,538 nmol/L) and controls (121 ± 18
nmol/L, p=0.120).
Discussion
This study demonstrated that enamel defects were significantly more prevalent and more
extensive in the permanent teeth of the affected group, comprised of isolated and combined
forms of methylmalonic acidemia, when compared to the control group (p<0.0001, Table 2).
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The DDE scores found in this study can be compared to the reported normal prevalence of
enamel defects of the facial surfaces of anterior teeth using the DDE Index: up to 5% of
teeth with diffuse opacities and 1% of teeth with hypoplasia (Clarkson and O'Mullane,
1989). Compared with this reported prevalence, the affected group is found to have a
significantly higher prevalence of severe enamel defects than the normal population
(p<0.0001). The presentation of the severe forms of enamel defects, seen as diffuse opacities
of enamel or as enamel hypoplasia (Figure 2), at a highly significant greater prevalence in
the study group compared to the controls suggests that these types of enamel defects are a
clinical expression of methylmalonic acidemia. Although only index teeth were analysed for
DDE, the finding of severe enamel defects in the maxillary anterior incisor teeth for affected
subjects can be generalized for all smooth surfaces of all teeth, in contrast to the isolated
enamel defects found on one or two teeth of the control group.
Affected subjects with mut MMA and adult index teeth had a significantly higher prevalence
of having at least one index tooth with a severe enamel defect (p = 0.021). Affected subjects
in this sub-group with a severe enamel defect also had higher serum methylmalonic acid
levels compared to those without enamel defects (p=0.017, Figure 3). Assuming that a
current elevated MMA level can be associated with a past history of difficult metabolic
control, this difference suggests that dysregulated metabolism during enamel development
may lead to developmental defects of enamel which are then permanent. Though kidney
transplant may influence serum methylmalonic acid levels, the association between enamel
defect score and serum methylmalonic acid remained when adjusted for transplant status
(p=0.040).
Markedly elevated levels of methylmalonate can also be indicative of renal involvement
(Walter et al., 1989). In pediatric populations, systemic disturbances that occur during
enamel development have been associated with enamel anomalies (Bhat and Nelson, 1989;
Pindborg, 1982), and renal dysfunction in particular has been linked with enamel hypoplasia
(Lucas and Roberts, 2005). Our results suggest that the current enamel defects may
retrospectively reflect pediatric disease, possibly renal insufficiency or a local influence of
MMA related biochemical malfunction at the site of tooth agenesis, which interfered with
normal enamel development. Enamel defects seen in permanent teeth of our study subjects
would then represent the permanent sequela of disturbed enamel formation during the first
seven years of life. The possible influence of renal disease is supported by our finding of
severe defects in the mut type subgroup (where renal disease is a significant complication)
and the association of severe defects with elevated serum methylmalonate levels.
Our analysis of affected subjects with primary index teeth suggests that primary teeth are
generally spared developmental defects of enamel in these disorders. However, the finding
of two cblC type MMA patients with severely dysmorphic primary teeth and extreme
hypoplastic enamel development (Figure 4), suggests that this subgroup may have dental
developmental problems in-utero, when these teeth begin calcification. This is supported by
the clinical observation of intrauterine growth retardation, and occasionally congenital
microcephaly, in this disease (Andersson et al., 1999).
These findings highlight the potential role of dental evaluation in the clinical assessment of
patients with methylmalonic acidemia and cobalamin metabolic disorders. In addition to
significant esthetic concerns, enamel defects may affect the caries status of the patient. An
association between enamel defects and a higher caries risk has been suggested (William et
al., 2006). For renal failure patients, however, there may be an association between enamel
defects and a lower incidence of caries, either secondary to the dental changes or to the
protective influence of altered salivary composition or influence on oral microflora (Lucas et
al., 2001; Lucas and Roberts, 2005).
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The identification of microstructural abnormalities seen in the primary tooth of an affected
patient with cblC deficiency further enhances our findings. Developmental defects of
enamel would be expected to manifest equally on both the incisor and molar sample since
the enamel of both types of teeth are expected to have the same microstructure of enamel.
Although limited to one tooth sample, the analysis shows ultrastructural anomalies that
appear to have occurred during enamel development, rather than post-formation attrition or
erosion of existing enamel. This suggest an alteration in the control of mineralization during
the mineralization and maturation phase of enamel formation (Wright et al., 1993). This type
of defect in enamel mineralization is indicative of a decreased mineral content that could
occur due to alterations in the formation and processing of the enamel matrix proteins or
changes in the control of the microenvironment during formation (Bartlett et al., 2006; Hart
et al., 2003; Phakey et al., 1995). Since this finding was in the primary dentition of a cblC
subject, it may reinforce our findings of severe enamel defects only in the primary dentition
of cblC patients. Also, the mut type patient who provided the primary molar for
microstructural analysis had only moderate levels of serum MMA (167μmol/L).
Analysis of salivary methylmalonic acid levels expands our clinical observations.
Methylmalonic acid levels were extremely elevated in the saliva from the two affected mut
subjects studied compared to controls (21,904 vs. 427 nmol/L), reflecting the subject's
matched serum levels (191,886 vs. 121 nmol/L). This raises the possibility of the use of
saliva as a non-invasive medium (Kaufman and Lamster, 2002; Tabak, 2001) for metabolic
monitoring in these disorders. Elevation of salivary methylmalonic acid may lead to
alterations in the oral microflora and salivary pH, which, in addition to the developmental
microstructural changes described, may further affect caries risk.
Conclusion
To date, this is the only study that has examined dental manifestations of patients with
methylmalonic acidemia and cobalamin disorders. Most US states now screen all newborns
using tandem mass spectrometry based methods that detect many inborn errors of
metabolism, including the disorders examined here (Therrell et al., 2006). It is certain that
more individuals will be diagnosed with a wide array of organic acidemias in the future, and
a better understanding of dental development in this group will be necessary for
comprehensive and interdisciplinary treatment.
This study presents the novel findings of enamel defects in a population of methylmalonic
acidemia and cobalamin disorder patients and the demonstration of massively elevated
levels of methylmalonate in the saliva of two mut subjects. Additionally, the enamel
anomalies documented here by clinical and microstructural analysis expands the phenotypic
manifestations of these inborn errors of metabolism and suggests that enamel development
may be altered in these disorders.
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Pathway of cellular processing of cobalamin (OH-cbl) and location of main enzyme defects
in the pathway leading to methylmalonic acidemias and cobalamin metabolic disorders.
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Control patient (row A) with normal enamel. Affected patients (row B – row E) showing
Developmental Defects of Enamel (right panel shows detail of the enamel defects of left
panel with arrows pointing to specific diffuse opacities and arrowheads pointing to
hypoplasia).
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Affected patients with mut type MMA and severe enamel defects, , have significantly*
higher serum levels of methylmalonic acid than those with normal enamel, .
*graph bars are mean ± 2 times the standard deviation
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Primary teeth from control subject and radiograph (row A). Severely dysmorphic, cone
shaped primary teeth and radiographic evidence of enamel hypoplasia in two affected
patient with cblC disorders (row B and C).
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Structural analyses of two affected patient's primary teeth. Tooth picture A, light microscopy
section C, and SEM picture E is of a primary molar donated by a mut type MMA patient.
Tooth picture B, light microscopy section D, and SEM picture F is of primary incisor
donated by a cblC patient.
Top row: Both teeth (A, B) demonstrated normal clinical morphology.
Middle row: Thin sections viewed with light microscope. Normal prismatic enamel (C)
compared with increased enamel opacity (D).
Bottom row: Sections viewed with SEM. Normal prism morphology (E) compared with
altered crystal structure (F).
Bassim et al. Page 15

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Oral Dis. Author manuscript; available in PMC 2010 April 1.
